BioSteel Supplementation and Performance
Launched by UNIVERSITY OF WESTERN ONTARIO, CANADA · Dec 17, 2013
Trial Information
Current as of June 29, 2025
Unknown status
Keywords
ClinConnect Summary
This study is expected to start in January 2014 and be completed by December 2014.
Ten exercise trained male athletes (18-35 years) will complete a repeated testing protocol under 2 experimental conditions in a systematically rotated blind crossover design: BSD and isoenergetic carbohydrate control, separated by 1 week. The testing protocol will consist of sprint interval exercise (4-repeated Wingate cycle tests, resistance at 10% body mass separated by 4 min recovery bouts, followed by 4 muscular fatigue and 2 cognitive function tests).
Approximately 1-2 weeks prior to testing, participa...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy, exercise-trained males aged 18-35 years. Participants can not have consumed BioSteel Sports Drink before. To ensure participants are highly trained, they must achieve the 2013 National Hockey League Combine average scores or better on 5 exercise tests (150 lb bench press, 8 lb sitting medicine ball toss, standing long jump, vertical jump and maximal oxygen consumption test on cycle ergometer). Women will be studied subsequently to asses andy gender differences.
- Exclusion Criteria:
- • Have symptoms or take medication for respiratory, cardiovascular, metabolic, neuromuscular disease.
- • Been diagnosed with a cognitive impairment and/or learning disability
- • Injury limiting exercise ability
- • Use of any medications with side effects of dizziness, lack of motor control, or slowed reaction time
- • Use of any other dietary supplements (excluding protein powder)
- • History of concussion/head injuries
- • Have an excessive alcohol intake (\>2 drinks/day)
- • Smoker
About University Of Western Ontario, Canada
The University of Western Ontario, located in Canada, is a prestigious academic institution dedicated to advancing knowledge and innovation in various fields, including health sciences. With a strong emphasis on research excellence, the university actively engages in clinical trials to explore new therapies, improve patient outcomes, and contribute to the global body of medical knowledge. Through collaboration with healthcare professionals and industry partners, the University of Western Ontario fosters a rigorous and ethical research environment, aiming to translate scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Trial Officials
Peter WR Lemon, Ph.D
Principal Investigator
Western University, Canada
Kolten C Abbott, B.Sc.
Study Director
Western University, Canada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials